How to Buy Rocket Pharmaceuticals Stock
Rocket Pharmaceuticals Inc
Rocket Pharmaceuticals, Inc. , together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases.
Rocket Pharmaceuticals stock last closed at $8.76, up 3.06% from the previous day, and has decreased 67.89% in one year. It has underperformed other stocks in the Biotechnology industry by 0.2 percentage points. Rocket Pharmaceuticals stock is currently +8.68% from its 52-week low of $8.06, and -69.45% from its 52-week high of $28.67.
There are currently 106.63M shares of RCKT outstanding. The market cap of RCKT is $934.08M. In the past 24 hours, 1.07M RCKT shares were traded.
How to Buy Rocket Pharmaceuticals Stock
Not sure how to invest in Rocket Pharmaceuticals stock? Here's how.
- Choose where to buy Rocket Pharmaceuticals stock: You need to pick an online brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you decide where to buy Rocket Pharmaceuticals stock.
- Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Fund your brokerage account: Choose your payment method and add your info.
- Analyze Rocket Pharmaceuticals stock: The Rocket Pharmaceuticals ticker symbol is RCKT. Is Rocket Pharmaceuticals stock a good investment? Should you buy shares of RCKT? How do RCKT's underlying business fundamentals look? Do top analysts think Rocket Pharmaceuticals is a good buy? Why has RCKT's stock price moved recently? (Hint: Our stock analysis website can help you evaluate if RCKT is a good stock to buy).
- Make your RCKT purchase: Decide if you will purchase RCKT shares at the current market price or use a limit order to buy RCKT stock at a particular price.
- Monitor your investment in RCKT: Create a watchlist to key updates about your investment in Rocket Pharmaceuticals stock.
Step 1: Choose where to buy Rocket Pharmaceuticals stock
You need an online brokerage account to access the NASDAQ market and buy RCKT stock.
Our favorite brokerage: eToro
Based on our experience, eToro is the best brokerage. eToro gives you:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world markets: From Tech to Real Estate, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro has a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've picked your brokerage, it's time to fill out some personal info so you are able to buy RCKT today.
How to Open a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to open your new trading account.
- Send your information by clicking the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you have filled out your info on the stock trading app, you can securely and quickly fund your account:
Watch the tutorial below if you need help depositing money into your brokerage account.
Step 4: Analyze Rocket Pharmaceuticals stock
Once you have chosen the best place to buy Rocket Pharmaceuticals stock, it's crucial to research their stock before you buy, so you can understand the risk as well as the upside.
Rocket Pharmaceuticals Metrics
RCKT Fundamentals
WallStreetZen was created to help everyday investors do better fundamental analysis.
You can see all of the due diligence checks on RCKT's stock page.
Is RCKT stock properly valued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge RCKT's intrinsic value.
Using relative valuations methods:
- RCKT could be undervalued based on its P/B ratio of 2.02x, relative to Biotechnology industry P/B ratio of 4.68x
You can access additional valuation analysis on RCKT's stock here.
RCKT Financial Summary
Passed Health Checks:
- There are more short-term assets than short-term liabilities on the RCKT balance sheet.
- Total RCKT debt is lower than 5 years ago, relative to shareholder equity.
- RCKT has cash burn of 215586000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the RCKT balance sheet.
- RCKT has a low debt to equity ratio of 0.14.
Failed Health Checks:
- RCKT has $374.23M in cash and short term investments. This is not enough to cover its annual cash burn of $215.59M.
Do Wall Street analysts think it's a good time to buy Rocket Pharmaceuticals stock
Out of 9 sell side analysts who give forecasts on RCKT, the consensus analyst rating on Rocket Pharmaceuticals is a Strong Buy
Please note that analyst forecasts are not recommendations, nor are they investment advice.
Most Recent RCKT Analyst Ratings
Gil Blum, a bottom 9% analyst from Needham maintains RCKT with a buy rating and lowers their RCKT price target from $52.00 to $42.00, on Feb 28, 2025.
Andrew Tsai, a bottom 10% analyst from Jefferies initiates coverage on RCKT with a strong buy rating and announces their RCKT price target of $29.00, on Dec 18, 2024.
Mani Foroohar, a bottom 2% analyst from Leerink Partners maintains RCKT with a buy rating and lowers their RCKT price target from $46.00 to $44.00, on Nov 19, 2024.
Joshua Schimmer, a top 1% analyst from Cantor Fitzgerald reiterates RCKT with a strong buy rating and maintains their RCKT price target from $65.00 to $65.00, on Nov 19, 2024.
You can dig deeper into what analysts are saying on the Rocket Pharmaceuticals stock forecast page.
Metrics for Advanced RCKT Traders
What are RCKT insiders up to?
In the last year, executives and large shareholders at RCKT have sold more shares than they have bought.
Jonathan David Schwartz, Chief Medical Gene Therapy Officer of RCKT, was the latest RCKT insider to sell. They sold $69,108.56 worth of RCKT shares on Feb 25, 2025.
Research more about who owns RCKT stock here.
Does RCKT provide a stable income stream?
No, Rocket Pharmaceuticals doesn't provide an income stream by paying out dividends.
What others are saying about RCKT
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Make your RCKT purchase
There are two main order types:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are mostly the easiest way to buy. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at an exact dollar amount, place a limit order.
Press the Open button and eToro will execute your order.
If you require additional help with buying stocks on eToro, click the helpful video below:
Step 6: Monitor your investment in RCKT
Now that you own some RCKT stock, you'll want to keep up with your investment.
Create a watchlist to see the latest developments about your RCKT stock.
RCKT Feed
How to Buy Stock in Rocket Pharmaceuticals
To summarize, here are the 6 steps to buy stock in Rocket Pharmaceuticals:
- Choose where to buy Rocket Pharmaceuticals stock
- Sign up for your brokerage account
- Fund your brokerage account
- Analyze Rocket Pharmaceuticals stock
- Make your RCKT purchase
- Monitor your investment in RCKT
If you need a brokerage account, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to get the latest news on your new investment in Rocket Pharmaceuticals, create a watchlist on WallStreetZen today.
More Stock Buying Guides You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.